Prudential Financial Inc Palatin Technologies Inc Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$0.36 - $0.79 $6,098 - $13,382	-16,940 Reduced 61.85%	10,450 $4,000
Q4 2019 Feb 11, 2020	BUY	$0.75 - $0.89 $12,172 - $14,444	16,230 Added 145.43%	27,390 $21,000
Q2 2019 Aug 08, 2019	BUY	$0.98 - $1.64 $392 - $656	400 Added 3.72%	11,160 $0
Q1 2019 May 15, 2019	SELL	$0.67 - $1.01 $14,878 - $22,428	-22,206 Reduced 67.36%	10,760 $0
Q4 2018 Feb 07, 2019	BUY	$0.63 - $1.0 $13,668 - $21,696	21,696 Added 192.51%	32,966 $23,000
Q3 2018 Nov 07, 2018	SELL	$0.88 - $1.1 $616 - $770	-700 Reduced 5.85%	11,270 $0
Q2 2018 Aug 13, 2018	BUY	$0.91 - $1.45 $10,892 - $17,356	11,970 New	11,970 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.